Cumberland Pharmaceuticals (CPIX) Price to Sales (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Price to Sales across 17 years of filings, most recently posting 583.27 for Q2 2026.

• In Q2 2026, Price to Sales rose 343.19% year-over-year to 583.27; the TTM figure through Jun 2026 stood at 3.11 (up 95.88% YoY), while the FY2025 annual figure was 1.34, up 53.11% from the prior year.
• Price to Sales came in at 583.27 for Q2 2026 at Cumberland Pharmaceuticals, up from 5.33 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 583.27 in Q2 2026 to a low of 1.93 in Q2 2023.
• Average Price to Sales over 5 years is 42.74, with a median of 3.11 recorded in 2023.
• Year-over-year, Price to Sales tumbled 57.19% in 2022 and jumped 5915.54% in 2025.
• Over 5 years, Price to Sales stood at 3.54 in 2022, then slipped by 23.72% to 2.7 in 2023, then rose by 17.25% to 3.17 in 2024, then surged by 37.34% to 4.35 in 2025, then surged by 13302.9% to 583.27 in 2026.
• Per Business Quant data, the three most recent Price to Sales figures were 583.27 in Q2 2026, 5.33 in Q1 2026, and 4.35 in Q4 2025.